Glendale Pharmacy Inc

Community/Retail Pharmacy



  
  2498 E Colorado Blvd, Pasadena
California, 91107-4250

 818-244-3164    818-244-1145
Glendale Pharmacy Inc is a Community/Retail Pharmacy in Pasadena, California. It is located at 2498 E Colorado Blvd, Pasadena and it's customer support contact number is 818-244-3164. The authorized person of Glendale Pharmacy Inc is Rita Avakian who is President of the pharmacy and his contact number is 818-521-4101. Glendale Pharmacy Inc accepts medicare which means medicare covered patients will not be billed for any more than the Medicare deductible and coinsurance.
Glendale Pharmacy Inc is a pharmacy where pharmacists store, prepare, and dispense medicinal preparations and/or prescriptions for a local patient population in accordance with federal and state law; counsel patients and caregivers (sometimes independent of the dispensing process); administer vaccinations; and provide other professional services associated with pharmaceutical care such as health screenings, consultative services with other health care providers, collaborative practice, disease state management, and education classes.


Pharmacy Details:
Glendale Pharmacy Inc type, location, contact phone number and fax are as below. Patients can directly walkin to the pharmacy or can call on the below given customer support phone number for enquiries.
Name: Glendale Pharmacy Inc
Type: Community/Retail Pharmacy
Location:2498 E Colorado Blvd, Pasadena,
California, 91107-4250
Phone:818-244-3164
Fax:818-244-1145
Authorized/Official Person Profile:
Officially authorized person to contact for any management issues or complaints of this pharmacy is as below. Person's position and contact details are also mentioned below.
Name: Rita Avakian
Position: President
Contact Number: 818-521-4101
Professional Identification Codes:
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details of given pharmacy are as mentioned below.
NPI Number: 1801807482
NPI Enumeration Date: 10 Aug, 2006
NPI Last Update On: 16 Apr, 2025

Medical Licenses:
Organizations can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Glendale Pharmacy Inc are as mentioned below.
SpecializationLicense NumberStateStatus
Community/Retail Pharmacy Primary
Durable Medical Equipment & Medical Supplies Secondary
Pharmacy Secondary
Managed Care Organization Pharmacy Secondary
Other Medical Identifiers:
Other legacy medical identifiers of the pharmacy such as Medicaid, Medicare PIN, NSC, UPIN etc. are mentioned as below.
IdentifierTypeStateIssuer
1990406OtherPk
PHA484210MedicaidCalifornia
Medicare Enrollment:
Glendale Pharmacy Inc is enrolled in medicare and it's Pac Id, enrollment Id, registered name and type is as stated below.
PAC ID: Enrollment ID: Org NameMedicare Entity Type
3870613847O20100930053256Glendale Pharmacy IncDME SUPPLIER - PHARMACY
Products Available:
Glendale Pharmacy Inc has following products available for sale under medicare.
Products:
•  Blood Glucose Monitors & Supplies: Non-mail Order•  Canes & Crutches
•  Enteral Nutrients•  Heat & Cold Applications
•  Nebulizer Equipment & Supplies•  Orthoses: Off-the-shelf
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address: 2498 E Colorado Blvd,
Pasadena, California
Zip: 91107-4250
Phone Number: 818-244-3164
Fax Number: 818-244-1145
Patients can reach Glendale Pharmacy Inc at 2498 E Colorado Blvd, Pasadena, California or can call on customer care at 818-244-3164.
Comments/ Reviews:
Read all the reviews posted for Glendale Pharmacy Inc below. You may also share your own experience with Glendale Pharmacy Inc. Your feedback can help others make better decisions.
**Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 08 December, 2025.